{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:59:15Z","timestamp":1790085555342,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopha.2026.119920","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:56:06Z","timestamp":1789012566000},"page":"119920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Red blood cell-based drug delivery systems: Construction strategies, biomedical applications, and future perspectives"],"prefix":"10.1016","volume":"203","author":[{"given":"Xiao","family":"Yuxin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2026.119920_bib1","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/pharmaceutics17081082","article-title":"Stimuli-responsive, cell-mediated drug delivery systems: engineering smart cellular vehicles for precision therapeutics","volume":"17","author":"Mashele","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2026.119920_bib2","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/10717544.2020.1831103","article-title":"Cell-mediated targeting drugs delivery systems","volume":"27","author":"Yu","year":"2020","journal-title":"Drug. Deliv."},{"issue":"2","key":"10.1016\/j.biopha.2026.119920_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tips.2020.11.008","article-title":"Biological cells as therapeutic delivery vehicles","volume":"42","author":"Bush","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2026.119920_bib4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2147\/IJN.S394389","article-title":"Cell-based drug delivery systems with innate homing capability as a novel nanocarrier platform","volume":"18","author":"Choi","year":"2023","journal-title":"Int. J. Nanomed."},{"issue":"10","key":"10.1016\/j.biopha.2026.119920_bib5","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.3390\/ijms22105264","article-title":"Nucleic acid delivery with red-blood-cell-based carriers","volume":"22","author":"Della Pelle","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119920_bib6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/adhm.201200138","article-title":"Erythrocyte-inspired delivery systems","volume":"1","author":"Hu","year":"2012","journal-title":"Adv. Healthc. Mater."},{"issue":"8","key":"10.1016\/j.biopha.2026.119920_bib7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.7150\/thno.11852","article-title":"Cell or cell membrane-based drug delivery systems","volume":"5","author":"Tan","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119920_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev-bioeng-121219-024239","article-title":"Red blood cell hitchhiking: a novel approach for vascular delivery of nanocarriers","volume":"23","author":"Brenner","year":"2021","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.biopha.2026.119920_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113992","article-title":"Red blood cells: the metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers","volume":"178","author":"Glassman","year":"2021","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2026.119920_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2478\/s11658-012-0001-z","article-title":"Red blood cell shape and deformability in the context of the functional evolution of its membrane structure","volume":"17","author":"Svetina","year":"2012","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.biopha.2026.119920_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1308632","article-title":"Drug transport by red blood cells","volume":"14","author":"Biagiotti","year":"2023","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119920_bib12","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/acs.bioconjchem.7b00758","article-title":"Red blood cells as smart delivery systems","volume":"29","author":"Han","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biopha.2026.119920_bib13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2147\/DDDT.S96470","article-title":"Drug-loaded erythrocytes: on the road toward marketing approval","volume":"10","author":"Bourgeaux","year":"2016","journal-title":"Drug. Des. Devel. Ther."},{"issue":"Pt A","key":"10.1016\/j.biopha.2026.119920_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2016.04.021","article-title":"Drug delivery with living cells","volume":"106","author":"Fliervoet","year":"2016","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2026.119920_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/17425247.2.2.311","article-title":"Erythrocyte-based drug delivery","volume":"2","author":"Rossi","year":"2005","journal-title":"Expert. Opin. Drug. Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2026.119920_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23451","article-title":"Drug-loaded erythrocytes: modern approaches for advanced drug delivery for clinical use","volume":"10","author":"Berikkhanova","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.biopha.2026.119920_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1152\/advan.00083.2016","article-title":"Measuring osmosis and hemolysis of red blood cells","volume":"41","author":"Goodhead","year":"2017","journal-title":"Adv. Physiol. Educ."},{"key":"10.1016\/j.biopha.2026.119920_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.addr.2018.06.012","article-title":"Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: so near and yet so far","volume":"132","author":"Thanuja","year":"2018","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2026.119920_bib19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.addr.2007.08.029","article-title":"Cell-based drug delivery","volume":"60","author":"Pierige","year":"2008","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"Pt A","key":"10.1016\/j.biopha.2026.119920_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.addr.2016.02.007","article-title":"Red blood cells: supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems","volume":"106","author":"Villa","year":"2016","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2026.119920_bib21","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1021\/acsnano.7b00133","article-title":"Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy","volume":"11","author":"Rao","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2026.119920_bib22","article-title":"Red blood cell-derived materials for cancer therapy: construction, distribution, and applications","volume":"24","author":"Ding","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biopha.2026.119920_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jconrel.2013.12.019","article-title":"Cell-penetrating peptides mediated encapsulation of protein therapeutics into intact red blood cells and its application","volume":"176","author":"He","year":"2014","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.biopha.2026.119920_bib24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","article-title":"Cell-penetrating peptides: from basic research to clinics","volume":"38","author":"Guidotti","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119920_bib25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12951-023-02060-5","article-title":"Red blood cells: a potential delivery system","volume":"21","author":"Chen","year":"2023","journal-title":"J. Nanobiotechnology"},{"issue":"5","key":"10.1016\/j.biopha.2026.119920_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/pharmaceutics12050440","article-title":"Vascular drug delivery using carrier red blood cells: Focus on RBC surface loading and pharmacokinetics","volume":"12","author":"Glassman","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2026.119920_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tmrv.2016.08.004","article-title":"Erythrocytes as carriers for drug delivery in blood transfusion and beyond","volume":"31","author":"Villa","year":"2017","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/j.biopha.2026.119920_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120084","article-title":"Red blood cell-hitchhiking chitosan nanoparticles for prolonged blood circulation time of vitamin K1","volume":"592","author":"Wang","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119920_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10717544.2016.1230903","article-title":"A novel strategy to achieve effective drug delivery: Exploit cells as carrier combined with nanoparticles","volume":"24","author":"Pang","year":"2017","journal-title":"Drug. Deliv."},{"issue":"23","key":"10.1016\/j.biopha.2026.119920_bib30","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.7150\/thno.36510","article-title":"Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery","volume":"9","author":"Sun","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119920_bib31","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3389\/fphys.2019.01070","article-title":"Red blood cell membrane processing for biomedical applications","volume":"10","author":"Rossi","year":"2019","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119920_bib32","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/17425247.2022.2108786","article-title":"Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics","volume":"19","author":"Wang","year":"2022","journal-title":"Expert. Opin. Drug. Deliv."},{"issue":"7","key":"10.1016\/j.biopha.2026.119920_bib33","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.7150\/thno.14471","article-title":"Safe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumors","volume":"6","author":"Luk","year":"2016","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.biopha.2026.119920_bib34","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.apsb.2019.01.011","article-title":"Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application","volume":"9","author":"Xia","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biopha.2026.119920_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.apsb.2017.11.009","article-title":"Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment","volume":"8","author":"Li","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"27","key":"10.1016\/j.biopha.2026.119920_bib36","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.biopha.2026.119920_bib37","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1007\/s11095-022-03328-5","article-title":"Red blood cell inspired strategies for drug delivery: Emerging concepts and new advances","volume":"39","author":"Zhang","year":"2022","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119920_bib38","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.athoracsur.2018.08.073","article-title":"Real age: red blood cell aging during storage","volume":"107","author":"Koch","year":"2019","journal-title":"Ann. Thorac. Surg."},{"issue":"3","key":"10.1016\/j.biopha.2026.119920_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1776","article-title":"Red blood cell membrane-derived nanoparticles: Applications and key challenges in their clinical translation","volume":"14","author":"Malhotra","year":"2022","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2026.119920_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112895","article-title":"Red blood cell membrane nanoparticles for tumor phototherapy","volume":"220","author":"Zheng","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"37","key":"10.1016\/j.biopha.2026.119920_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201901442","article-title":"On command drug delivery via cell-conveyed phototherapeutics","volume":"15","author":"Marvin","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.biopha.2026.119920_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biomaterials.2017.11.002","article-title":"Nanoscaled red blood cells facilitate breast cancer treatment by combining photothermal\/photodynamic therapy and chemotherapy","volume":"155","author":"Wan","year":"2018","journal-title":"Biomaterials"},{"issue":"17","key":"10.1016\/j.biopha.2026.119920_bib43","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.3390\/ijms26178143","article-title":"Cell-based drug delivery systems: Innovative drug transporters for targeted therapy","volume":"26","author":"Sergazy","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"35","key":"10.1016\/j.biopha.2026.119920_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201802006","article-title":"Aggressive man-made red blood cells for hypoxia-resistant photodynamic therapy","volume":"30","author":"Liu","year":"2018","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.biopha.2026.119920_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12057","article-title":"Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery","volume":"10","author":"Pham","year":"2021","journal-title":"J. Extracell. Vesicles"},{"issue":"3","key":"10.1016\/j.biopha.2026.119920_bib46","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1021\/acsnano.1c11374","article-title":"Dual affinity to RBCs and target cells (DART) enhances both organ- and cell type-targeting of intravascular nanocarriers","volume":"16","author":"Ferguson","year":"2022","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.biopha.2026.119920_bib47","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.molmed.2018.05.003","article-title":"Focus on fundamentals: achieving effective nanoparticle targeting","volume":"24","author":"Tietjen","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biopha.2026.119920_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1663092","article-title":"Biomimetic erythrocyte-based drug delivery systems for organ-targeted therapy","volume":"13","author":"Zhu","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119920_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017132","article-title":"Newly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compounds","volume":"6","author":"Cinti","year":"2011","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.biopha.2026.119920_bib50","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13036-025-00537-5","article-title":"Erythrocyte-based achiral micromotors for localized therapeutic delivery","volume":"19","author":"Wang","year":"2025","journal-title":"J. Biol. Eng."},{"issue":"11","key":"10.1016\/j.biopha.2026.119920_bib51","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.7150\/thno.11848","article-title":"Biomimetic acoustically-responsive vesicles for theranostic applications","volume":"5","author":"Hsieh","year":"2015","journal-title":"Theranostics"},{"issue":"22","key":"10.1016\/j.biopha.2026.119920_bib52","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.1039\/D1NR01916C","article-title":"Ultrasound responsive erythrocyte membrane-derived hybrid nanovesicles with controlled drug release for tumor therapy","volume":"13","author":"Wang","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2026.119920_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.905256","article-title":"Recent progress in red blood cell-derived particles as novel bioinspired drug delivery systems: Challenges and strategies for clinical translation","volume":"10","author":"Vincy","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.biopha.2026.119920_bib54","first-page":"481","article-title":"Red blood cell-derived components as biomimetic functional materials: matching versatile delivery strategies based on structure and function","volume":"47","author":"Liu","year":"2025","journal-title":"Bioact. Mater."},{"issue":"4","key":"10.1016\/j.biopha.2026.119920_bib55","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1517\/17425241003610633","article-title":"Drug delivery by red blood cells: vascular carriers designed by mother nature","volume":"7","author":"Muzykantov","year":"2010","journal-title":"Expert. Opin. Drug. Deliv."},{"issue":"25","key":"10.1016\/j.biopha.2026.119920_bib56","doi-asserted-by":"crossref","first-page":"22141","DOI":"10.1021\/acsami.9b04827","article-title":"Red blood cell-derived vesicles for delivery of lipophilic drug camptothecin","volume":"11","author":"Malhotra","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.biopha.2026.119920_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202201690","article-title":"Versatile red blood cells for triple-negative breast cancer treatment via stepwise photoactivations","volume":"12","author":"Cheng","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"8","key":"10.1016\/j.biopha.2026.119920_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002533","article-title":"Revised estimates for the number of human and bacteria cells in the body","volume":"14","author":"Sender","year":"2016","journal-title":"PLoS. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119920_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65185-1","article-title":"Multiscale red blood cell hitchhiking for targeted deep tissue gene delivery in lungs","volume":"16","author":"Park","year":"2025","journal-title":"Nat. Commun."},{"issue":"49","key":"10.1016\/j.biopha.2026.119920_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aea6618","article-title":"Red blood cell-hitchhiking fluorescent probe to promote intraoperative diagnosis of human tumors","volume":"11","author":"Lin","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2026.119920_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/smll.74818","article-title":"Shear-responsive red blood cell carriers for targeted drug delivery to constricted arteries","volume":"22","author":"Amar","year":"2026","journal-title":"Small"},{"key":"10.1016\/j.biopha.2026.119920_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2025.1730142","article-title":"Use of encapsulated dexamethasone sodium phosphate (eDSP) in chronic obstructive pulmonary disease","volume":"5","author":"Horn","year":"2025","journal-title":"Front. Drug. Deliv."},{"key":"10.1016\/j.biopha.2026.119920_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114987","article-title":"Red blood cell mediated drug delivery: Loading, release and clinical progress","volume":"395","author":"Deng","year":"2026","journal-title":"J. Control. Release"},{"issue":"31","key":"10.1016\/j.biopha.2026.119920_bib64","doi-asserted-by":"crossref","first-page":"22645","DOI":"10.1021\/acs.langmuir.6c01982","article-title":"Erythrocyte membrane incorporation modulates the stability and fusion-associated behavior of biomimetic vesicles","volume":"42","author":"Sousa","year":"2026","journal-title":"Langmuir"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600956X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600956X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:59:39Z","timestamp":1790081979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222600956X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":64,"alternative-id":["S075333222600956X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119920","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Red blood cell-based drug delivery systems: Construction strategies, biomedical applications, and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119920"}}